Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Oct-24 5:03 PM View:  | Maxcyte, Inc. (MXCT) | 02-Oct-24 | Option Exercise | 21,607 | $0.04 | $864.28 | 8% 269.12K to 290.73K | |
| 02-Oct-24 5:03 PM View: | Maxcyte, Inc. (MXCT) | 02-Oct-24 | Planned Option Sale | 21,607 | $3.71 | $80,162.00 | (7%) 290.73K to 269.12K | |
| 02-Oct-24 5:03 PM View: | Maxcyte, Inc. (MXCT) | 01-Oct-24 | Option Exercise | 26,082 | $0.04 | $1,043.28 | 10% 269.12K to 295.2K | |
| 02-Oct-24 5:03 PM View: | Maxcyte, Inc. (MXCT) | 01-Oct-24 | Planned Option Sale | 26,082 | $3.78 | $98,590.00 | (9%) 295.2K to 269.12K | |
| 13-Jun-24 5:37 PM View: | Maxcyte, Inc. (MXCT) | 11-Jun-24 | Grant | 21,367 | -- | -- | 9% 247.75K to 269.12K | |
| 16-Dec-22 5:00 PM View: | Novavax, Inc. (NVAX) | 14-Dec-22 | Payment of Exercise | 2,320 | $17.23 | $39,973.60 | (6%) 38.81K to 36.49K | |
| 16-Dec-22 5:00 PM View: | Novavax, Inc. (NVAX) | 14-Dec-22 | Option Exercise | 6,966 | -- | -- | 22% 31.85K to 38.81K | |
| 28-Sep-22 5:02 PM View: | Novavax, Inc. (NVAX) | 26-Sep-22 | Payment of Exercise | 2,180 | $18.87 | $41,136.60 | (6%) 34.03K to 31.85K | |
| 28-Sep-22 5:02 PM View: | Novavax, Inc. (NVAX) | 26-Sep-22 | Option Exercise | 6,546 | -- | -- | 24% 27.48K to 34.03K | |
| 16-Dec-21 5:14 PM View: | Novavax, Inc. (NVAX) | 14-Dec-21 | Payment of Exercise | 3,366 | $168.43 | $566,935.00 | (11%) 30.85K to 27.48K | |
| 16-Dec-21 5:14 PM View: | Novavax, Inc. (NVAX) | 14-Dec-21 | Option Exercise | 6,967 | -- | -- | 29% 23.88K to 30.85K | |
| 05-Oct-21 5:05 PM View: | Novavax, Inc. (NVAX) | 04-Oct-21 | Option Exercise | 42,829 | $27.45 | $1,175,580.00 | 179% 23.88K to 66.71K | |
| 05-Oct-21 5:05 PM View: | Novavax, Inc. (NVAX) | 04-Oct-21 | Market Option Sale (Planned) | 42,829 | $176.15 | $7,544,200.00 | (64%) 66.71K to 23.88K | |
| 05-Oct-21 5:04 PM View: | Novavax, Inc. (NVAX) | 01-Oct-21 | Option Exercise | 49,000 | $27.17 | $1,331,400.00 | 205% 23.88K to 72.88K | |
| 05-Oct-21 5:04 PM View: | Novavax, Inc. (NVAX) | 01-Oct-21 | Market Option Sale (Planned) | 49,000 | $175.10 | $8,580,060.00 | (67%) 72.88K to 23.88K | |
| 28-Sep-21 5:02 PM View: | Novavax, Inc. (NVAX) | 26-Sep-21 | Payment of Exercise | 3,162 | $248.16 | $784,682.00 | (12%) 27.04K to 23.88K | |
| 28-Sep-21 5:02 PM View: | Novavax, Inc. (NVAX) | 26-Sep-21 | Option Exercise | 6,546 | -- | -- | 32% 20.5K to 27.04K | |
| 18-Nov-20 6:09 PM View: | Novavax, Inc. (NVAX) | 16-Nov-20 | Option Exercise | 52,317 | $37.14 | $1,942,800.00 | 255% 20.49K to 72.81K | |
| 18-Nov-20 6:09 PM View: | Novavax, Inc. (NVAX) | 16-Nov-20 | Market Option Sale (Planned) | 52,316 | $90.65 | $4,742,670.00 | (72%) 72.81K to 20.5K | |
| 01-Oct-20 5:39 PM View: | Novavax, Inc. (NVAX) | 01-Oct-20 | Market Sale (Planned) | 2 | $108.57 | $217.13 | (< 1%) 20.5K to 20.49K | |
| 01-Oct-20 5:39 PM View: | Novavax, Inc. (NVAX) | 30-Sep-20 | Market Sale (Planned) | 12,231 | $110.23 | $1,348,200.00 | (37%) 32.73K to 20.5K | |
| 30-Sep-20 9:27 PM View: | Novavax, Inc. (NVAX) | 29-Sep-20 | Market Option Sale (Planned) | 4,112 | $107.80 | $443,267.00 | (11%) 36.84K to 32.73K | |
| 30-Sep-20 9:27 PM View: | Novavax, Inc. (NVAX) | 28-Sep-20 | Disposition | 1,338 | $111.18 | $148,759.00 | (2%) 74.61K to 73.27K | |
| 30-Sep-20 9:27 PM View: | Novavax, Inc. (NVAX) | 28-Sep-20 | Payment of Exercise | 11,429 | $111.18 | $1,270,680.00 | (16%) 73.27K to 61.84K | |
| 30-Sep-20 9:27 PM View: | Novavax, Inc. (NVAX) | 28-Sep-20 | Option Exercise | 50,000 | $5.95 | $297,500.00 | 203% 24.61K to 74.61K | |
| 30-Sep-20 9:27 PM View: | Novavax, Inc. (NVAX) | 28-Sep-20 | Market Option Sale (Planned) | 25,000 | $110.30 | $2,757,460.00 | (40%) 61.84K to 36.84K | |
| 29-Sep-20 6:16 PM View: | Novavax, Inc. (NVAX) | 26-Sep-20 | Payment of Exercise | 2,434 | $113.56 | $276,405.00 | (9%) 27.04K to 24.61K | |
| 29-Sep-20 6:16 PM View: | Novavax, Inc. (NVAX) | 26-Sep-20 | Option Exercise | 6,546 | -- | -- | 32% 20.49K to 27.04K | |
| 10-Mar-20 4:58 PM View: | Novavax, Inc. (NVAX) | 08-Mar-20 | Payment of Exercise | 1,992 | $12.48 | $24,860.20 | (9%) 22.49K to 20.49K | |
| 10-Mar-20 4:58 PM View: | Novavax, Inc. (NVAX) | 08-Mar-20 | Option Exercise | 6,072 | -- | -- | 37% 16.41K to 22.49K | |
| 30-Nov-18 4:02 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 28-Nov-18 | Option Exercise | 8,333 | $1.49 | $12,416.20 | 21% 40.0K to 48.33K | |
| 15-May-18 11:13 AM View: | Novavax, Inc. (NVAX) | 14-May-18 | Market Purchase | 100,000 | $1.65 | $164,620.00 | 44% 228.28K to 328.28K | |
| 13-Nov-17 8:13 AM View: | Novavax, Inc. (NVAX) | 09-Nov-17 | Market Purchase | 100,000 | $1.13 | $113,050.00 | 78% 128.28K to 228.28K | 69% |
| 11-May-17 10:29 AM View: | Novavax, Inc. (NVAX) | 11-May-17 | Market Purchase | 50,000 | $0.84 | $41,980.00 | 64% 78.28K to 128.28K | 128% |
| 01-Apr-16 5:34 PM View: | Novavax, Inc. (NVAX) | 31-Mar-16 | Option Exercise | 201,991 | $1.28 | $258,548.00 | 196% 103.06K to 305.05K | |
| 01-Apr-16 5:34 PM View: | Novavax, Inc. (NVAX) | 31-Mar-16 | Market Option Sale | 201,991 | $5.18 | $1,047,160.00 | (66%) 305.05K to 103.06K | 63% |
| 01-Apr-16 5:34 PM View: | Novavax, Inc. (NVAX) | 31-Mar-16 | Market Sale | 24,778 | $5.18 | $128,454.00 | (24%) 103.06K to 78.28K | 63% |
| 01-Apr-16 5:34 PM View: | Novavax, Inc. (NVAX) | 30-Mar-16 | Option Exercise | 198,009 | $1.28 | $253,452.00 | 192% 103.06K to 301.07K | |
| 01-Apr-16 5:34 PM View: | Novavax, Inc. (NVAX) | 30-Mar-16 | Market Option Sale | 198,009 | $5.19 | $1,028,000.00 | (66%) 301.07K to 103.06K | 63% |
| 01-Feb-16 5:30 PM View: | Novavax, Inc. (NVAX) | 31-Jan-16 | Private Purchase | 2,072 | $4.38 | $9,075.36 | 2% 100.98K to 103.06K | |
| 04-Aug-15 4:43 PM View: | Novavax, Inc. (NVAX) | 31-Jul-15 | Private Purchase | 3,207 | $2.28 | $7,311.96 | 3% 97.78K to 100.98K | |
| 03-Feb-15 5:04 PM View: | Novavax, Inc. (NVAX) | 31-Jan-15 | Private Purchase | 6,122 | $2.28 | $13,958.20 | 7% 91.66K to 97.78K | |
| 04-Aug-14 3:11 PM View: | Novavax, Inc. (NVAX) | 31-Jul-14 | Private Purchase | 6,788 | $2.28 | $15,476.60 | 8% 84.87K to 91.66K | |
| 25-Mar-14 12:02 PM View: | Novavax, Inc. (NVAX) | 25-Mar-14 | Market Purchase | 10,000 | $4.27 | $42,698.00 | (11%) 94.87K to 84.87K | 70% |
| 04-Feb-14 9:19 AM View: | Novavax, Inc. (NVAX) | 31-Jan-14 | Private Purchase | 11,868 | $2.29 | $27,177.70 | 19% 63.0K to 74.87K | |
| 23-Aug-11 9:33 AM View: | Novavax, Inc. (NVAX) | 19-Aug-11 | Market Purchase | 13,000 | $1.26 | $16,380.00 | 100% 0 to 13.0K | 0% |
| 11-Aug-11 10:15 AM View: | Novavax, Inc. (NVAX) | 10-Aug-11 | Market Purchase | 16,552 | $1.24 | $20,524.50 | 100% 0 to 16.55K | 2% |
| 11-Aug-11 10:15 AM View: | Novavax, Inc. (NVAX) | 09-Aug-11 | Market Purchase | 33,448 | $1.24 | $41,475.50 | 100% 0 to 33.45K | 2% |
| 16-Mar-09 8:07 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 12-Mar-09 | Market Purchase | 40,000 | $1.22 | $48,880.00 | 100% 0 to 40.0K | 509% |
| 07-Aug-08 6:12 PM View: | Intercell Usa, Inc. (IOMID) | 05-Aug-08 | Disposition | 25,001 | $6.60 | $165,007.00 | (100%) 25.0K to 0 | < 1% |